The Beauty Health Company (NASDAQ:SKIN) Shares Sold by Braidwell LP

Braidwell LP decreased its stake in The Beauty Health Company (NASDAQ:SKIN - Free Report) by 20.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,049,694 shares of the company's stock after selling 1,070,991 shares during the quarter. Braidwell LP owned approximately 3.27% of Beauty Health worth $5,832,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Caprock Group LLC acquired a new stake in Beauty Health in the 2nd quarter worth about $38,000. Sanctuary Advisors LLC purchased a new position in shares of Beauty Health in the second quarter valued at approximately $47,000. SG Americas Securities LLC acquired a new stake in shares of Beauty Health in the third quarter worth approximately $37,000. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Beauty Health during the second quarter worth approximately $105,000. Finally, Russell Investments Group Ltd. acquired a new position in Beauty Health in the 1st quarter valued at $279,000. Institutional investors and hedge funds own 93.26% of the company's stock.

Beauty Health Stock Up 0.7 %

NASDAQ SKIN traded up $0.01 on Friday, reaching $1.48. 273,499 shares of the company were exchanged, compared to its average volume of 971,123. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56. The business's fifty day moving average price is $1.57 and its 200 day moving average price is $1.77. The Beauty Health Company has a fifty-two week low of $0.91 and a fifty-two week high of $5.17.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Canaccord Genuity Group lifted their target price on shares of Beauty Health from $1.25 to $1.75 and gave the stock a "hold" rating in a research note on Wednesday, November 13th. Piper Sandler reissued an "underweight" rating and issued a $1.00 price target (down from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $2.55.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.